QP 18 - Bio 5: Genomics and Biomarkers II

Moderator(s)

• 

  Corey Speers, MD, PhD

  Case Western Reserve University/University Hospitals Cleveland Medical Center
  Cleveland, OH, United States
• 

  Everett Moding, MD, PhD

  Stanford University
  Stanford, CA

Presentations:

• 5:15 PM – 5:20 PM ET

  Introduction
• 5:20 PM – 5:25 PM ET

  Cu-64-Anti-CEA M5A as a Novel Theranostics PET Imaging Agent Pre and Post Neoadjuvant Radiotherapy in Advanced Rectal Cancer
  

  Presenter: Jeffrey Wong, MD, FASTRO – City of Hope National Medical Center
• 5:25 PM – 5:30 PM ET

  Luminal B Single-Cell Signature and Resistance to Hormone Therapy in Breast Cancer
  

  Presenter: William Chen, MD – UCSF
• 5:30 PM – 5:35 PM ET

  Genomic Predictors of Response to Metastasis Directed Therapy with or without Androgen Deprivation Therapy
  

  Presenter: Philip Sutera, MD – Johns Hopkins Radiation Oncology Kimmel Cancer Center
• 5:35 PM – 5:40 PM ET

  Urine Cell-Free DNA Analysis to Detect Tumor Tissue of Origin and Predict Pathologic Complete Response across Genitourinary Malignancies
  

  Presenter: Pradeep Chauhan, PhD – Mayo Clinic Rochester
• 5:40 PM – 5:45 PM ET

  Genomic Characterization of Radiotherapy-Associated Muscle Invasive Bladder Cancer after Prostate Cancer Treatment
  

  Presenter: N. Ari Wijetunga, MD, PhD, MS – University of North Carolina
• 5:45 PM – 5:50 PM ET

  Impact of Cancer Therapy on Clonal Hematopoiesis Mutations and Subsequent Clinical Outcomes
  

  Presenter: Kevin Nead, MD, MPhil – MD Anderson Cancer Center
• 5:50 PM – 6:10 PM ET

  Questions and Answers
• 6:10 PM – 6:15 PM ET

  Closing